GSK3-IN-9 (0713) is a selective inhibitor of glycogen synthase kinase 3 (GSK3). It holds potential for research into fragile X syndrome, attention deficit hyperactivity disorder (ADHD), childhood epilepsy, intellectual disabilities, diabetes, acute myeloid leukemia (AML), autism, and mental disorders.
Molecular Weight:
308.378
CAS Number:
[748145-12-2]
Formula:
C18H20N4O
Target:
GSK-3
T205647
* VAT and and shipping costs not included. Errors and price changes excepted
